Dr. Gabriel Sosne

OphthalmologyComprehensive Ophthalmologist
Detroit, MI
(313) 577-8900
Accepts Medicare

Location

4717 St. Antoine
Detroit, MI 48201

Areas of Expertise

Dry Eye
Diabetic Eye Disease
Macular Degeneration
Inflammatory Eye Diseases
External Eye Diseases
Advertisements

About Me

Dr. Gabriel Sosne is an ophthalmologist practicing at the Kresge Eye Institute in Detroit. He specializes in the diagnosis and treatment of cataracts, dry eye disease, and a variety of other eye conditions, including macular degeneration, glaucoma, and inflammatory eye diseases. He also conducts diabetic eye examinations and manages external eye disorders.

Dr. Sosne earned his medical degree from Albert Einstein College of Medicine and completed his residency at Henry Ford Hospital. He then pursued a fellowship at the National Institutes of Health, where he engaged in research on thymosin β4 as a potential therapy for dry eye. His clinical interests are reflected in his active research and publications on dry eye and corneal health.

Publications & Press

  • Thymosin beta 4 Significantly Improve Signs and Symptoms of Severe Dry Eye in a Phase 2 Clinical Trial

    CORNEA
  • Thymosin β4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-Controlled Phase 2 Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model

    Expert Opinion
  • Thymosin β4 Significantly Reduces the Signs of Dry Eye in a Murine Controlled Adverse Environment Model of Experimental Dry Eye

    Expert Opinion
  • Thymosin β4: A Multi-Functional Regenerative Peptide Basic Properties and Clinical Applications

    Expert Opin Biol Ther2012
  • Thymosin β4: a potential novel dry eye therapy

    Ann N Y Acad Sci2012
  • Thymosin beta 4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK

    FASEB J2011
  • Biological activities of thymosin beta 4 defined by active sites in short peptide sequences

    FASEB J2010
  • Treatment of Chronic Non-Healing Neurotrophic Corneal Epithelial Defects with Thymosin 4

    Ann N Y Acad Sci2010
  • Treatment of Chronic Nonhealing Neurotrophic Corneal Epithelial Defects With Thymosin Beta 4

    Arch Ophthalmol2010
  • Thymosin beta 4 suppression of corneal NFkappaB: A potential anti-inflammatory pathway

    Exp Eye Res2007

Certifications & Licensure

Licensed In
MI
License Numbers
4301064247